Active · per the CBE, 18 September 2026
Apotheek Tobback logo

Apotheek Tobback

BE0832737575

Rechtspersoon Private limited company 1 establishment

Apotheek Tobback is a pharmacy in Tervuren. Private Limited, started on 6 January 2011, 1 establishment.

Kerkstraat 19, 3080 Tervuren apotheektobbacktervuren.apotheek.be 027673314 [email protected]

Behind the company: Kristof Tobback, Mieke Meyfroots.

Active for

15 year, 8 months

Financials

Financial year 2025

Apotheek Tobback from Tervuren, company number BE0832737575, closed financial year 2025 with a result of € 273,324 after tax. For that financial year Apotheek Tobback recorded a gross margin of € 417,487 and equity of € 1 million. Compared with financial year 2024, the result moved from € 268,422 to € 273,324. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Healthy

€ 1 million

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 273,324

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 424,210

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 467,254 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 3,116

▼ 64% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 32,804

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,936

▲ 70% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 336,784 € 409,493 € 415,252 € 417,487 ▲ 1%
Profit after taxes € 212,234 € 274,513 € 268,422 € 273,324 ▲ 2%
Equity € 812,489 € 956,261 € 1,224,683 € 1,030,753 ▼ 16%
Total debts € 143,030 € 116,538 € 70,686 € 36,798 ▼ 48%
Cash € 414,568 € 504,648 € 565,833 € 424,210 ▼ 25%
Land & buildings € 192,292 € 175,024 € 157,756 € 140,489 ▼ 11%
Retained profit € 800,089 € 955,861 € 1,224,283 € 1,030,353 ▼ 16%
Dividend € 0 € 118,741 € 0 € 467,254
Bank debt € 97,126 € 63,183 € 28,874 € 0 ▼ 100%
Balance sheet total € 955,519 € 1,072,799 € 1,295,370 € 1,067,550 ▼ 18%

Key figures of Apotheek Tobback, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Apotheek Tobback?

What happened at Apotheek Tobback in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 273,324 (▲ 2% vs 2024). Source: NBB ↗
  • New establishment in Tervuren. KBO
  • Start of the company according to the CBE. KBO

In short

From € 212,234 profit in 2022 to € 273,324 profit in 2025.

Paid € 459,905 in corporate taxes since 2022.

Best year ever: 2023, with € 274,513 profit.

Paid out € 585,996 in dividends to the owners in total.

Management

Kristof Tobback
Mieke Meyfroots
Apotheek Tobback

Behind Apotheek Tobback are Kristof Tobback and Mieke Meyfroots. The shares are held by Kristof Tobback and Mieke Meyfroots.

See the full network in the app

Directors

According to the 2025 annual accounts

Kristof Tobback

Director

Is a shareholder

Mieke Meyfroots

Director

Is a shareholder

Shareholders

Kristof Tobback · director

Mieke Meyfroots · director

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkstraat 19

3080 Tervuren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsPHPSwiperWP RocketWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja
Languages FR, NL

Features

Webshop Blog Ads Contact page

Security

HTTPS
SPF
DMARC

Network

IPv6
Load balancing

Details

Company number
0832.737.575
VAT number
BE 0832.737.575
Registered office
Kerkstraat 19, 3080 Tervuren
Names & denominations
Apotheek Tobback
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
6 January 2011
Peppol
Active · Active since 19 Nov 2025
Activities · NACE

Detailhandel in farmaceutische producten

Vervaardiging van overige farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Frequently asked questions

What does Apotheek Tobback do?
Apotheek Tobback is a pharmacy in Tervuren. Private Limited, started on 6 January 2011, 1 establishment.
What is the address of Apotheek Tobback?
The registered office of Apotheek Tobback is located at Kerkstraat 19, 3080 Tervuren.
Is Apotheek Tobback still active?
Yes. According to the CBE (18 September 2026) Apotheek Tobback is active, legal situation “Normale toestand”, started on 6 January 2011.
Is Apotheek Tobback registered on Peppol?
Yes, Apotheek Tobback is registered on the Peppol network with ID 0208:0832737575.
What is the enterprise number of Apotheek Tobback?
The enterprise number of Apotheek Tobback is BE0832737575.
When was Apotheek Tobback founded?
Apotheek Tobback was founded on 6 January 2011.